American International Group Inc. boosted its holdings in shares of Healthequity Inc (NASDAQ:HQY) by 8.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 39,609 shares of the company’s stock after buying an additional 2,993 shares during the quarter. American International Group Inc. owned approximately 0.07% of Healthequity worth $2,003,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. BlackRock Inc. grew its position in Healthequity by 4.3% during the second quarter. BlackRock Inc. now owns 5,831,014 shares of the company’s stock valued at $290,559,000 after buying an additional 241,061 shares during the period. Vanguard Group Inc. grew its position in Healthequity by 3.0% during the second quarter. Vanguard Group Inc. now owns 4,237,298 shares of the company’s stock valued at $211,145,000 after buying an additional 122,061 shares during the period. Wasatch Advisors Inc. grew its position in Healthequity by 2.2% during the second quarter. Wasatch Advisors Inc. now owns 2,442,180 shares of the company’s stock valued at $121,694,000 after buying an additional 52,885 shares during the period. FMR LLC grew its position in Healthequity by 45.6% during the second quarter. FMR LLC now owns 2,235,150 shares of the company’s stock valued at $111,378,000 after buying an additional 699,728 shares during the period. Finally, Janus Henderson Group PLC grew its position in Healthequity by 627.9% during the second quarter. Janus Henderson Group PLC now owns 2,113,030 shares of the company’s stock valued at $105,292,000 after buying an additional 1,822,732 shares during the period. Institutional investors own 98.60% of the company’s stock.

In other news, major shareholder Berkley Capital, Llc sold 373,500 shares of the business’s stock in a transaction on Monday, November 6th. The shares were sold at an average price of $53.21, for a total value of $19,873,935.00. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Stephen Neeleman sold 8,500 shares of the business’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $45.24, for a total transaction of $384,540.00. Following the completion of the transaction, the insider now directly owns 1,000 shares in the company, valued at approximately $45,240. The disclosure for this sale can be found here. Insiders sold 1,743,212 shares of company stock worth $91,145,351 in the last three months. Insiders own 29.00% of the company’s stock.

Healthequity Inc (NASDAQ HQY) opened at $45.72 on Monday. Healthequity Inc has a 1-year low of $37.62 and a 1-year high of $55.31. The firm has a market cap of $2,773.97, a P/E ratio of 65.31, a price-to-earnings-growth ratio of 1.99 and a beta of 1.74.

Healthequity (NASDAQ:HQY) last issued its quarterly earnings results on Tuesday, December 5th. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.13 by $0.04. Healthequity had a net margin of 21.08% and a return on equity of 14.47%. The business had revenue of $56.80 million for the quarter, compared to the consensus estimate of $55.27 million. During the same quarter in the previous year, the firm earned $0.10 earnings per share. The company’s revenue for the quarter was up 31.0% on a year-over-year basis. analysts predict that Healthequity Inc will post 0.71 earnings per share for the current fiscal year.

HQY has been the topic of several analyst reports. Zacks Investment Research raised shares of Healthequity from a “hold” rating to a “buy” rating and set a $58.00 price target on the stock in a report on Wednesday, October 11th. BidaskClub raised shares of Healthequity from a “sell” rating to a “hold” rating in a report on Thursday, September 28th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $56.00 price target on shares of Healthequity in a report on Tuesday, August 29th. Robert W. Baird reaffirmed a “hold” rating on shares of Healthequity in a report on Thursday, September 21st. Finally, Oppenheimer reaffirmed a “buy” rating and set a $61.00 price target on shares of Healthequity in a report on Wednesday, September 6th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and eight have issued a buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $58.33.

TRADEMARK VIOLATION NOTICE: “American International Group Inc. Acquires 2,993 Shares of Healthequity Inc (HQY)” was originally published by Watch List News and is the property of of Watch List News. If you are viewing this story on another publication, it was copied illegally and republished in violation of US & international trademark and copyright legislation. The original version of this story can be viewed at https://www.watchlistnews.com/american-international-group-inc-acquires-2993-shares-of-healthequity-inc-hqy/1756767.html.

Healthequity Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Institutional Ownership by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.